How long does Ozempic (semaglutide) stay in the system of a typical adult patient with normal renal and liver function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long Ozempic Stays in Your System

Ozempic (semaglutide) has an elimination half-life of approximately 7 days (1 week), meaning it remains in your circulation for about 5 weeks after the last dose. 1

Pharmacokinetic Timeline

Half-Life and Elimination

  • Semaglutide has a half-life of approximately 7 days, which is what allows for once-weekly dosing 1, 2
  • The drug will be present in the circulation for approximately 5 weeks (about 35 days) after your last dose 1
  • This extended presence is due to the drug's extensive binding to plasma albumin (>99%) and slow clearance rate 1

Time to Steady State

  • Steady-state exposure is achieved after 4-5 weeks of once-weekly administration 1, 2
  • This means it takes about a month of regular weekly injections for the drug to reach consistent levels in your system 1

Absorption and Peak Concentration

  • Maximum concentration is reached 1-3 days after each injection 1
  • The absolute bioavailability is 89% when administered subcutaneously 1

Metabolism and Excretion

How the Body Processes Semaglutide

  • The primary elimination route is through metabolism via proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid side chain 1
  • The apparent clearance in patients with type 2 diabetes is approximately 0.05 L/h, which is quite slow 1

Excretion Pathways

  • Only approximately 3% of the dose is excreted in urine as intact semaglutide 1
  • The remainder is excreted as metabolites via both urine and feces 1

Clinical Implications of Extended Duration

Weight Regain After Stopping

  • Significant weight regain occurs after discontinuation, with patients regaining 11.6% of lost weight over 52 weeks after stopping treatment 3
  • In one trial, patients who transitioned to placebo after 20 weeks of treatment regained 6.9% of lost weight during 48 weeks of placebo administration 3
  • This underscores that semaglutide requires long-term, potentially lifelong use to maintain weight loss benefits 3

Factors That Don't Affect Duration

  • Age, sex, race, ethnicity, and renal impairment do not have clinically meaningful effects on semaglutide pharmacokinetics 1
  • Hepatic impairment does not impact semaglutide exposure 1
  • Body weight affects exposure (higher weight = lower exposure), but the standard doses provide adequate coverage across the weight range of 40-198 kg 1

Important Caveats

Drug Interactions

  • The delay in gastric emptying caused by semaglutide may influence absorption of oral medications, though clinical studies showed no clinically relevant interactions with commonly co-administered drugs (metformin, oral contraceptives, warfarin, digoxin, atorvastatin) 1
  • Semaglutide has very low potential to inhibit or induce CYP enzymes or drug transporters 1

Missed Doses

  • If you miss 2 consecutive doses, you can resume at the same dose if previously well-tolerated 4
  • If you miss 3 or more consecutive doses, consider restarting the full titration schedule 4

The 5-week presence in your system after stopping means that both therapeutic effects and potential side effects may persist for over a month after your last injection, which is crucial for planning any medication changes or surgical procedures.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Semaglutide-Based Therapies for Weight Management and Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.